Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Andrew D. Krystal |
Documentos disponibles escritos por este autor (3)
Refinar búsquedaA double blind, placebo controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression / Andrew D. Krystal en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 1 (Enero)
Título : A double blind, placebo controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression Tipo de documento: texto impreso Autores: Andrew D. Krystal, Autor ; John R. Harsh, Autor ; Ronghua Yang, Autor Fecha de publicación: 2022 Artículo en la página: pp. 32-40 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Compuestos de bencidrilo, Estimulantes del sistema nervioso central, Presión positiva, Trastorno depresivo mayor, Trastornos de somnolencia excesiva, Trastorno distímico, Síndromes de apnea del sueño. Resumen: Treatment of excessive sleepiness in the context of obstructive sleep apnea (OSA) may be particularly difficult in those with depression because depression and/or antidepressant medications may cause sleepiness and fatigue in addition to that due to the OSA. This study evaluating armodafinil, a nonamphetamine wakefulness-promoting medication, is the first trial for treatment of excessive sleepiness in patients with treated OSA and comorbid depression. Link: ./index.php?lvl=notice_display&id=28123
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 1 (Enero) . - pp. 32-40[artículo] A double blind, placebo controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression [texto impreso] / Andrew D. Krystal, Autor ; John R. Harsh, Autor ; Ronghua Yang, Autor . - 2022 . - pp. 32-40.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 1 (Enero) . - pp. 32-40
Palabras clave: Antidepresivos, Compuestos de bencidrilo, Estimulantes del sistema nervioso central, Presión positiva, Trastorno depresivo mayor, Trastornos de somnolencia excesiva, Trastorno distímico, Síndromes de apnea del sueño. Resumen: Treatment of excessive sleepiness in the context of obstructive sleep apnea (OSA) may be particularly difficult in those with depression because depression and/or antidepressant medications may cause sleepiness and fatigue in addition to that due to the OSA. This study evaluating armodafinil, a nonamphetamine wakefulness-promoting medication, is the first trial for treatment of excessive sleepiness in patients with treated OSA and comorbid depression. Link: ./index.php?lvl=notice_display&id=28123
Título : New developments in insomnia medications of relevance to mental health disorders Tipo de documento: texto impreso Autores: Andrew D. Krystal, Autor Fecha de publicación: 2020 Artículo en la página: pp. 843-860 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Personalización, Insomnio, Trastornos psiquiátricos comórbidos, Suvorexant, Doxepina, Prazosina, Eszopiclona Resumen: Many insomnia medications with high specificity have become available recently. They provide a window into the clinical effects of modulating specific brain systems and establish a new guiding principal for conceptualizing insomnia medications: "mechanism matters." Link: ./index.php?lvl=notice_display&id=24196
in Psychiatric Clinics of North America > Año 2015 - Vol.38 No.4 (Diciembre) . - pp. 843-860[artículo] New developments in insomnia medications of relevance to mental health disorders [texto impreso] / Andrew D. Krystal, Autor . - 2020 . - pp. 843-860.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2015 - Vol.38 No.4 (Diciembre) . - pp. 843-860
Palabras clave: Personalización, Insomnio, Trastornos psiquiátricos comórbidos, Suvorexant, Doxepina, Prazosina, Eszopiclona Resumen: Many insomnia medications with high specificity have become available recently. They provide a window into the clinical effects of modulating specific brain systems and establish a new guiding principal for conceptualizing insomnia medications: "mechanism matters." Link: ./index.php?lvl=notice_display&id=24196
Título : Sleep and psychiatric disorders : future directions Tipo de documento: texto impreso Autores: Andrew D. Krystal, Autor Fecha de publicación: 2020 Artículo en la página: pp. 1115-1130 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Terapia farmacológica, Trastornos mentales, Trastornos del sueño y vigilia. Resumen: Understanding of the relationship between co-occurring sleep and psychiatric disorders has undergone a radical change. The longstanding perspective that sleep problems invariably are a symptom of a psychiatric disorder is giving way to understanding that complex bidirectional relationships may exist. Link: ./index.php?lvl=notice_display&id=24586
in Psychiatric Clinics of North America > Año 2006 - Vol. 29 No. 4 (Diciembre) . - pp. 1115-1130[artículo] Sleep and psychiatric disorders : future directions [texto impreso] / Andrew D. Krystal, Autor . - 2020 . - pp. 1115-1130.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2006 - Vol. 29 No. 4 (Diciembre) . - pp. 1115-1130
Palabras clave: Terapia farmacológica, Trastornos mentales, Trastornos del sueño y vigilia. Resumen: Understanding of the relationship between co-occurring sleep and psychiatric disorders has undergone a radical change. The longstanding perspective that sleep problems invariably are a symptom of a psychiatric disorder is giving way to understanding that complex bidirectional relationships may exist. Link: ./index.php?lvl=notice_display&id=24586
